Literature DB >> 17508142

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.

Nicolaas I Bohnen1, Satyanarayana Gedela, Hiroto Kuwabara, Gregory M Constantine, Chester A Mathis, Stephanie A Studenski, Robert Y Moore.   

Abstract

Olfactory dysfunction is a frequent and early feature of Parkinson's disease (PD), often preceding the motor symptoms by several years. Assessment of olfactory deficits may be used in the diagnostic assessment of PD. In this study we investigated the relationship between selective deficits in smell identification and nigrostriatal dopaminergic denervation in patients with PD. Twenty-seven PD patients (Hoehn and Yahr stages I-III) and 27 healthy controls matched for gender and age underwent olfactory testing using the 40-odor University of Pennsylvania Smell Identification Test (UPSIT). PD patients underwent (11)C-beta-CFT dopamine transporter (DAT) positron emission tomography (PET) imaging and clinical motor examination. We found that total UPSIT scores were significantly lower in the PD than in the control subjects (z=4.7, p<0.0001). Analysis of the individual smell scores identified 3 odors with an accuracy of >0.75 for the diagnosis of PD. These odors were banana, licorice, and dill pickle. A PD-specific smell identification score (UPSIT-3) was calculated for these 3 odors. Analysis of the patient PET data demonstrated significant correlations between dorsal striatal DAT activity and the UPSIT-3 (R(S)=0.53, p=0.0027) and total UPSIT (R(S)=0.44, p=0.023) scores. UPSIT-3 (R(S)=0.43, p=0.027) but not total UPSIT (R(S)=0.20, ns) correlated with nigral DAT activity. We conclude that patients with PD have selective hyposmia. A simplified UPSIT smell identification test consisting of 3 PD-selective odors had more robust correlation with nigral and dorsal striatial dopaminergic activity compared with the full UPSIT scores in patients with PD. Assessment of selective olfactory deficits may be used as a simplified olfactory screening test in the evaluation of subjects with possible PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17508142     DOI: 10.1007/s00415-006-0284-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  45 in total

1.  Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain.

Authors:  Masanori Ichise; Jeih-San Liow; Jian-Qiang Lu; Akihiro Takano; Kendra Model; Hiroshi Toyama; Tetsuya Suhara; Kazutoshi Suzuki; Robert B Innis; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2003-09       Impact factor: 6.200

2.  Impaired olfactory function in Parkinson's disease.

Authors:  J Lehrner; T Brücke; I Kryspin-Exner; S Asenbaum; I Podreka
Journal:  Lancet       Date:  1995-04-22       Impact factor: 79.321

3.  Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb.

Authors:  Beate Winner; Martin Geyer; Sebastien Couillard-Despres; Robert Aigner; Ulrich Bogdahn; Ludwig Aigner; Georg Kuhn; Jürgen Winkler
Journal:  Exp Neurol       Date:  2005-10-24       Impact factor: 5.330

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 6.  The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential.

Authors:  K Ray Chaudhuri; L Yates; P Martinez-Martin
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

Review 7.  Olfaction and Parkinson's syndromes: its role in differential diagnosis.

Authors:  Regina Katzenschlager; Andrew J Lees
Journal:  Curr Opin Neurol       Date:  2004-08       Impact factor: 5.710

8.  Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease.

Authors:  R L Doty; M B Stern; C Pfeiffer; S M Gollomp; H I Hurtig
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

9.  Improved synthesis of some commonly used PET radioligands by the use of [11C]methyl triflate.

Authors:  K Någren; L Müller; C Halldin; C G Swahn; P Lehikoinen
Journal:  Nucl Med Biol       Date:  1995-02       Impact factor: 2.408

10.  Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Authors:  R L Doty; D A Deems; S Stellar
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

View more
  39 in total

1.  A cross-sectional study contrasting olfactory function in autonomic disorders.

Authors:  E M Garland; S R Raj; A C Peltier; D Robertson; I Biaggioni
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

2.  Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging.

Authors:  Matthew R Woodward; Muhammad Ubaid Hafeez; Qianya Qi; Ahmed Riaz; Ralph H B Benedict; Li Yan; Kinga Szigeti
Journal:  Am J Geriatr Psychiatry       Date:  2018-04-19       Impact factor: 4.105

Review 3.  Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.

Authors:  Michelle E Fullard; James F Morley; John E Duda
Journal:  Neurosci Bull       Date:  2017-08-22       Impact factor: 5.203

Review 4.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

5.  Orthostatic hypotension, non-dipping and striatal dopamine in Parkinson disease.

Authors:  Yoon-Sang Oh; Joong-Seok Kim; Yong-An Chung; Ie Ryung You; Dong-Won Yang; Sung-Woo Chung; Jeong-Wook Park; Yeong-In Kim; Kwang-Soo Lee
Journal:  Neurol Sci       Date:  2012-08-15       Impact factor: 3.307

6.  Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.

Authors:  Ming Cao; Zhu-Qin Gu; Yuan Li; Hui Zhang; Xiao-Juan Dan; Shan-Shan Cen; Da-Wei Li; Piu Chan
Journal:  Neurosci Bull       Date:  2016-10-03       Impact factor: 5.203

Review 7.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

8.  Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael A Kilbourn; Roger L Albin; Kirk A Frey
Journal:  Brain       Date:  2010-04-22       Impact factor: 13.501

9.  Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo.

Authors:  Haiyan Lou; Susana E Montoya; Tshianda N M Alerte; Jian Wang; Jianjun Wu; Xiangmin Peng; Chang-Sook Hong; Emily E Friedrich; Samantha A Mader; Courtney J Pedersen; Brian S Marcus; Alison L McCormack; Donato A Di Monte; S Colette Daubner; Ruth G Perez
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

10.  2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.

Authors:  Julie L Wang; Ajit K Parhi; Shunichi Oya; Brian Lieberman; Mei-Ping Kung; Hank F Kung
Journal:  Nucl Med Biol       Date:  2008-05       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.